Delayed clearance of intraabdominal abscesses caused by Candida albicans in tumor necrosis factor-α- and lymphotoxin-α-deficient mice

Journal of Infectious Diseases

Volumn 186, Issue 12, 2002, Pages 1815-1822

  Vonk, Alieke G ^a   Netea, Mihai G ^a   Van Krieken, Johan H ^a   Van der Meer, Jos W M ^a   Kullberg, Bart Jan ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; LYMPHOTOXIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABDOMINAL ABSCESS; ARTICLE; BACTERIAL GROWTH; CANDIDA ALBICANS; CELL KILLING; CYTOKINE PRODUCTION; DISEASE MODEL; EFFECTOR CELL; FEMALE; GRANULOCYTE; HELPER CELL; HOST RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SPECIES DIFFERENCE; SPLEEN CELL; WILD TYPE;

ABDOMINAL ABSCESS; ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; CELLS, CULTURED; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; FEMALE; GRANULOCYTES; INTERFERON TYPE II; INTERLEUKIN-10; LYMPHOTOXIN-ALPHA; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SPLEEN; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037115076     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/345818     Document Type: Article

References (25)

1. Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996;334:1717-25.
2. Gruss HJ. Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily. Int J Clin Lab Res 1996;26:143-59.
3. Parrillo JE, Parker MM, Natanson C, et al. Septic shock in humans: Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990; 113:227-42.
4. Tracey KJ, Fong Y, Hesse DG, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330:662-4.
5. Bagby GJ, Plessala KJ, Wilson LA, Thompson JJ, Nelson S. Divergent efficacy of antibody to tumor necrosis factor-α in intravascular and peritonitis models of sepsis. J Infect Dis 1991; 163:83-8.
6. Echtenacher B, Falk W, Mannel DN, Krammer PH. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol 1990; 145:3762-6.
7. Echtenacher B, Hultner L, Mannel DN. Cellular and molecular mechanisms of TNF protection in septic peritonitis. J Inflamm 1995;47:85-9.
8. Netea MG, Blok WL, Kullberg BJ, et al. Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. J Infect Dis 1995; 171:393-9.
9. Steinshamn S, Waage A. Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice. Infect Immun 1992;60:4003-8.
10. Netea MG, van Tits LJ, Curfs JH, et al. Increased susceptibility of TNF-α lymphotoxin-α double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. J Immunol 1999; 163:1498-505.
11. Mencacci A, Cenci E, Del Sero G, et al. Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-α double-deficient mice infected with Candida albicans. Int Immunol 1998; 10:37-48.
12. Warris A, Bjorneklett A, Gaustad P. Invasive pulmonary aspergillosis associated with infliximab therapy. N Engl J Med 2001;344:1099-100.
13. Amiot F, Boussadia O, Cases S, et al. Mice heterozygous for a deletion of the tumor necrosis factor-α and lymphotoxin-α genes: Biological importance of a nonlinear response of tumor necrosis fautor-α to gene dosage. Eur J Immunol 1997;27:1035-42.
14. Kullberg BJ, van't Wout JW, van Furth R. Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1. Infect Immun 1990;58:3319-24.
15. Gaviria JM, van Burik JA, Dale DC, Root RK, Liles WC. Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo. J Infect Dis 1999; 179:1301-4.
16. Vonk AG, Wieland CW, Netea MG, Kullberg BJ. Phagocytosis and intracellular killing of Candida albicans blastoconidia by neutrophils and macrophages: A comparison of different microbiological test systems. J Microbiol Methods 2002;49:55-62.
17. Netea MG, Demacker PN, Kullberg BJ, et al. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J Clin Invest 1996;97:1366-72.
18. Cuff CA, Schwartz J, Bergman CM, et al. Lymphotoxin α3 induces chemokines and adhesion molecules: Insight into the role of LTα in inflammation and lymphoid organ development. J Immunol 1998; 161:6853-60.
19. Bopst M, Garcia I, Guler R, et al. Differential effects of TNF and LTα in the host defense against M. bovis BCG. Eur J Immunol 2001;31:1935-43.
20. Ehlers S, Benini J, Kutsch S, et al. Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium. Infect Immun 1999;67:3571-9.
21. Gibson FC, Onderdonk AB, Kasper DL, Tzianabos AO. Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis. J Immunol 1998; 160:5000-6.
22. Flynn JL, Goldstein MM, Chan J, et al. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995;2:561-72.
23. Ashman RB, Papadimitriou JM. Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol Rev 1995;59:646-72.
24. Vazquez Torres A, Balish E. Macrophages in resistance to candidiasis. Microbiol Mol Biol Rev 1997;61:170-92.
25. Tripp CS, Wolf SF, Unanue ER. Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 1993;90:3725-9.